APA (7th ed.) Citation
(2026). Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy. PLOS ONE.
Chicago Style (17th ed.) Citation
"Correction: Low Level of Plasma DNase Is Associated with Worse Clinical Outcome in Testicular Germ Cell Tumor Patients and Exogeneous DNase I Improves Cisplatin Treatment Efficacy." PLOS ONE 2026.
MLA (9th ed.) Citation
"Correction: Low Level of Plasma DNase Is Associated with Worse Clinical Outcome in Testicular Germ Cell Tumor Patients and Exogeneous DNase I Improves Cisplatin Treatment Efficacy." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.